slides · global inventory
Expose Contradiction
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 14,162
Current window 9,811-9,840
Pages 473
Rows per page 30
Slide function
9,811-9,840 of 14,162
108
The slide uses direct quotes from former consultants to substantiate claims of corporate misconduct.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
109
The slide uses direct quotes from KOLs to frame the company's management as deceptive and manipulative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
110
The slide uses a direct quote to frame the company's behavior as deceptive.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
111
The slide uses direct quotes from KOLs to frame the company as unethical and manipulative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
112
The slide uses highlighted text to emphasize key claims about doctor behavior and financial incentives.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
113
The slide uses aggressive, accusatory language and highlights specific quotes from KOLs to frame Nevro's business practices as unethical and similar to the Insys scandal.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
114
Uses a 'gotcha' interview format to frame the company's business model as deceptive.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
115
Uses testimonial evidence from KOLs to support the claim of corporate deception.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
116
The slide uses a direct quote from a KOL to frame the company's sales tactics as unethical and deceptive.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
117
Uses testimonial-style quotes from KOLs to build a case of corporate misconduct.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
118
The slide uses direct quotes from consultants to substantiate claims of corporate misconduct.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
119
The slide uses direct quotes from a KOL to support the claim of unethical sales practices and patient manipulation.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
121
Uses direct quotes to frame Nevro as a 'one-trick pony' lacking sophistication compared to competitors.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
122
Uses direct quotes to undermine the company's value proposition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
123
The slide uses expert testimony to frame Nevro's business model as unsustainable once 'low-hanging fruit' markets are exhausted.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
124
The slide uses highlighted text to emphasize key claims about market share loss and device failure.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
125
The slide uses expert testimony to undermine the company's market position and stock performance.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
126
The slide uses a testimonial from a former employee to undermine the credibility of the company's historical clinical trial success.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
127
The slide uses direct quotes from a former employee to frame the company's therapy as ineffective compared to marketing claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
128
The slide uses yellow highlighting to emphasize key negative feedback points from the former employee.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
129
The slide uses a Q&A format to highlight the discrepancy between appropriate clinical use and the company's sales practices.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
130
Uses a diagram to contrast the company's marketing claims against the activist's critical interpretation of the product's 'versatility'.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
131
Uses direct quotes from the company's own SEC filings to highlight hypocrisy.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
132
Uses a direct quote from the CEO to highlight a discrepancy between expected adoption of new features and actual usage.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
133
Uses CEO quote to undermine management credibility.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
134
Uses testimonial quotes to undermine company narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
137
Uses expert quotes to undermine the company's product strategy.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
138
Uses direct quotes from KOLs to undermine the company's product launch narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
140
Uses expert testimony to undermine company narrative regarding product success.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
141
The slide uses direct quotes from former employees to undermine the company's product strategy.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit